Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Neoplasms 4Vomiting 3Nausea 2Anorexia 2Weight Loss 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Opioid-Related Disorders 1Muscular Atrophy 1Multiple Myeloma 1Lung Neoplasms 1Hematologic Neoplasms 1Gynecologic Cancer 1Gliosarcoma 1Glioblastoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Child Nutrition Disorders 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Breast Neoplasms 1

Interventions

Olanzapine 3Dexamethasone 3Palonosetron 2Ondansetron 2Control Groups 2phenazine 1peppermint oil 1naldemedine 1almond oil 1Surveys and Questionnaires 1Standard of Care 1Promethazine 1Laser Therapy 1Imagery, Psychotherapy 1Growth Differentiation Factor 15 1Granisetron 1Famotidine 1Electric Stimulation 1Diphenhydramine 1Calcium Dobesilate 1Aromatherapy 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Vomiting × Olanzapine × 1 year × Clear all
NCT07403370 2026-05-19

Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis

Shandong Cancer Hospital and Institute

Completed
2,000 enrolled

Nausea, Vomiting

NCT03118986 2025-10-08

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

The Hospital for Sick Children

Phase 2 Recruiting
200 enrolled

Nausea, Neoplasms, Vomiting

NCT07035821 2025-06-25

Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy

Shanghai Children's Medical Center

Phase 3 Not yet recruiting
100 enrolled

Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡